EUTM file information

018721102

BIOVERSE


June 20, 2022

Trademark Summary

The trademark BIOVERSE was filed by Oliver Dickinson, a national of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on August 11, 2022, and received one opposition filed on November 9, 2022 by BIOVER N.V. on Likelihood of confusion. the opponent was represented by FENCER and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 9, 2022

The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Acne medication
    2. Anti-cancer drugs
    3. Anti-inflammatories
    4. Antibiotics
    5. Cannabis for medical purposes
    6. Chemical preparations for medical purposes
    7. Chinese traditional medicinal herbs
    8. Cultures for medical use
    9. Crude drugs
    10. Dermatological pharmaceutical products
    11. Dietary supplements
    12. Drugs for medical purposes
    13. Elixirs [pharmaceutical preparations]
    14. Extracts of medicinal herbs
    15. Extracts of medicinal plants
    16. Food supplements
    17. Food supplements for medical purposes
    18. Gummy vitamins
    19. Herbal medicine
    20. Medical preparations
    21. Medicine
    22. Medicine tonics
    23. Neutraceutical preparations for humans
    24. Pharmaceutical compositions
    25. Pharmaceutical creams
    26. Pharmaceutical drugs
    27. Pharmaceutical preparations
    28. Pharmaceuticals
    29. Pharmaceuticals and natural remedies
    30. Plant and herb extracts for medicinal use
    31. Plant extracts for pharmaceutical use
    32. Preparations of vitamins
    33. Preparations for the treatment of acne
    34. Preparations for use in naturopathy
    35. Probiotic preparations for medical use
    36. Vaccines
    37. Viral antigens
    38. Vitamin supplements.